These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23525613)

  • 1. Objective criteria for crohn-like lymphoid reaction in colorectal cancer.
    Ueno H; Hashiguchi Y; Shimazaki H; Shinto E; Kajiwara Y; Nakanishi K; Kato K; Maekawa K; Miyai K; Nakamura T; Yamamoto J; Hase K
    Am J Clin Pathol; 2013 Apr; 139(4):434-41. PubMed ID: 23525613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative validation of assessment criteria for Crohn-like lymphoid reaction in colorectal carcinoma.
    Kim JH; Kim KJ; Bae JM; Rhee YY; Cho NY; Lee HS; Kang GH
    J Clin Pathol; 2015 Jan; 68(1):22-8. PubMed ID: 25322692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and significance of colorectal cancer associated lymphoid reaction.
    Väyrynen JP; Sajanti SA; Klintrup K; Mäkelä J; Herzig KH; Karttunen TJ; Tuomisto A; Mäkinen MJ
    Int J Cancer; 2014 May; 134(9):2126-35. PubMed ID: 24154855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.
    Rozek LS; Schmit SL; Greenson JK; Tomsho LP; Rennert HS; Rennert G; Gruber SB
    J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27172903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.
    Mlecnik B; Tosolini M; Kirilovsky A; Berger A; Bindea G; Meatchi T; Bruneval P; Trajanoski Z; Fridman WH; Pagès F; Galon J
    J Clin Oncol; 2011 Feb; 29(6):610-8. PubMed ID: 21245428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's-Like Lymphoid Reaction is Associated with Oncological Prognosis and Nutritional Status in Patients with Pathological Stage II/III Gastric Cancer.
    Omura Y; Toiyama Y; Okugawa Y; Yamamoto A; Yin C; Kusunoki K; Kusunoki Y; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Kusunoki M
    Ann Surg Oncol; 2020 Jan; 27(1):259-267. PubMed ID: 31414294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
    Katz SC; Pillarisetty V; Bamboat ZM; Shia J; Hedvat C; Gonen M; Jarnagin W; Fong Y; Blumgart L; D'Angelica M; DeMatteo RP
    Ann Surg Oncol; 2009 Sep; 16(9):2524-30. PubMed ID: 19568816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma.
    Correale P; Rotundo MS; Botta C; Del Vecchio MT; Ginanneschi C; Licchetta A; Conca R; Apollinari S; De Luca F; Tassone P; Tagliaferri P
    Clin Cancer Res; 2012 Feb; 18(3):850-7. PubMed ID: 22142823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
    Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM
    Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases.
    Barresi V; Reggiani Bonetti L; Vitarelli E; Di Gregorio C; Ponz de Leon M; Barresi G
    Am J Surg Pathol; 2012 Jan; 36(1):66-72. PubMed ID: 21989343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer.
    Huh JW; Lee JH; Kim HR
    Arch Surg; 2012 Apr; 147(4):366-72. PubMed ID: 22508783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
    Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
    Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells.
    Oshikiri T; Miyamoto M; Morita T; Fujita M; Miyasaka Y; Senmaru N; Yamada H; Takahashi T; Horita S; Kondo S
    Clin Cancer Res; 2006 Jan; 12(2):411-6. PubMed ID: 16428480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of preoperative immunonutrition and other nutrition models on tumor infiltrative lymphocytes in colorectal cancer patients.
    Caglayan K; Oner I; Gunerhan Y; Ata P; Koksal N; Ozkara S
    Am J Surg; 2012 Oct; 204(4):416-21. PubMed ID: 23010614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ILT3 predicts poor prognosis and is inversely associated with infiltration of CD45RO+ T cells in patients with colorectal cancer.
    Liu J; Lu CX; Zhang F; Lv W; Liu C
    Pathol Res Pract; 2018 Oct; 214(10):1621-1625. PubMed ID: 30126665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
    J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator.
    Graham DM; Appelman HD
    Mod Pathol; 1990 May; 3(3):332-5. PubMed ID: 2362940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer.
    Maoz A; Dennis M; Greenson JK
    Front Immunol; 2019; 10():1884. PubMed ID: 31507584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis.
    Lashner BA; Bauer WM; Rybicki LA; Goldblum JR
    Am J Gastroenterol; 2003 Jun; 98(6):1423-7. PubMed ID: 12818291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.